Obesity, Fat Intake and Chronic Disease

George Bray
Pennington Biomedical Research Center
Louisiana State University
6400 Perkins Road
Baton Rouge, Louisiana 70808


REFERENCES

  1. AACE/ACE Obesity Task Force. AACE/ACE Position Statement on th ePrevention, Diagnosis and Treatment of Obesity (1998 Revision). Endocrine Practice 1998;4:297-350.

  2. Alexander JK. The cardiomyopathy of obesity. Prog Cardiovasc Dis 1985;27(5):325-334.

  3. Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci 1993;306:117-123.

  4. Ashley FW, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis 1974;27:103-114.

  5. Blundell JE, Halford JCG. Serotonin and appetite regulation- implications for the pharmacological treatment of obesity (review). Int J Eat Disord 1998;9(6):473-495.

  6. Boosalis MG, Gemayel N, Lee A, Bray GA, Laine L, Cohen H. Cholecystokinin and satiety: Effect of hypothalamic obesity and gastric bubble insertion. Am J Physiol 1992;262 (Regulatory Integrative Comp Physiol 31):R241-R244.

  7. Bouchard C, Despres J, Mauriege P. Genetic and nongenetic determinants of regional fat distribution (review). Endocr Rev 1993;14(1):72-93.

  8. Bradden FE, Rodgers B, Wadsworth ME, Davies JM. Onset of obesity in the 36-year birth cohort study. BMJ 1986;293:299-303.

  9. Bray GA. Obesity, a disorder of nutrient partitioning: The Mona Lisa Hypothesis. J Nutr 1991;121:1146-1162.

  10. Bray GA. Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am J Clin Nutr 1992;55:265S-271S.

  11. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr 1998;68(6):1157-1173

  12. Bray GA, Bouchard C, James WPT (eds). Handbook of Obesity. New York: Marcel Dekker, Inc., 1997.

  13. Bray GA. Contemporary diagnosis and the management of obesity. Newton, PA: Handbooks in Health Care, 1998.

  14. Bray GA. Future developments of pharmacology. IN: Clinical Obesity. P. Kopelman and M. Stock (eds). Oxford: Blackwell Science, Ltd, pp 508-544, 1998.

  15. Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K. A double-blind randomized placebo controlled trial of sibutramine. Obes Res 1996;4:263-270.

  16. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB. Sibutramine produces dose-related weight loss. Obes Res 1999, in press.

  17. Calingasan NY, Ritter S. Hypothalamic paraventricular nucleus lesions do not abolish glucoprivic or lipoprivic feeding. Brain Res 1992;595(1):25-31.

  18. Campfield LA, Brandon P, Smith FJ. On-line continuous measurement of blood glucose and meal pattern in free-feeding rats: The role of glucose in meal initiation. Brain Res Bull 1985;14(6):605-616.

  19. Casey VA, Dwyer JT, Coleman KA, Valadian I. Body mass index from childhood to middle age: a 50-year follow-up. Am J Clin Nutr 1992;56:14-18.

  20. Clement K, Vaisse C, Lahlou N. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.

  21. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122(7):481-486.

  22. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-588.

  23. DeFronzo RA, Ferranni E. Insulin resistance - A multifaceted syndrome responsible for NIDDM obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14(3):173-194.

  24. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986.

  25. Donato K, Hegsted DM. Efficiency of utilization of various sources of energy for growth. Proc Natl Acad Sci U S A 1985;82:4866-4870.

  26. Erlanson-Albertsson C, York D. Enterostatin - A peptide regulating fat intake. Obes Res 1997;5(4):360-372.

  27. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Ann Intern Med 1992;116:535-539.

  28. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes 1998;22(1):39-47.

  29. Flatt JP. Assessment of Daily and Cumulative Carbohydrate and Fat Balances in Mice (Technical Note). J Nutr Biochem 1991;2(4):193-202.

  30. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101(3):515-520.

  31. Forbes GB. Human body composition: growth, aging, nutrition and activity. New York: Springer-Verlag, 1987.

  32. Friedman MI. Body-fat and the metabolic control of food-intake. Int J Obes 1990;14(S3):53-67.

  33. Fujimoto K, Machidori H, Iwakiri R, et al. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res 1993;608:233-237.

  34. Geary N. Pancreatic glucagon signals postprandial satiety. Neurosci Biobehav Rev 1990;14:323-338.

  35. Gilbertson TA, Fontenot DT, Liu L, Zhang H, Monroe WT. Fatty acid modulation of K+ channels in taste receptor cells: gustatory cues for dietary fat. Am J Physiol 1997;272:C1203-1210.

  36. Grundy SM, Barnett JP. Metabolic and health complications of obesity (Review). Dis Mon 1990;36(12):641-696.

  37. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non- insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 1987;36:43-51.

  38. Hamm P, Shekelle RB, Stamler J. Large fluctuations in body weight during young adulthood and twenty-five-year risk of coronary death in men. Am J Epidemiol 1989;129:312-318.

  39. Heymsfield SB, Wang J, Heshka S, Kehayias JJ, Pierson RN. Dual-photon absorptiometry: comparison of bone mineral and soft tissue mass measurements in vivo with established methods. Am J Clin Nutr 1989;49(6):1283-1289.

  40. Heymsfield SB, Waki M, Kehayias J, et al. Chemical and elemental analysis of humans in vivo using improved body composition models. Am J Physiol 1991;261(2pt1):E190-E198.

  41. Hollander P, Elbein SC, Hirsch IB, et al. Role of Orlistat in the treatment of obese patients with type 2 diabetes. Diab Care 21:1288-1294.

  42. Jhanwar-Uniyal M, Roland CR, Leibowitz SF. Diurnal rhythm of alpha 2-noradrenergic receptors in the paraventricular nucleus and other brain areas: relation to circulating corticosterone and feeding behavior. Life Sci 1986;38(5):473-482.

  43. Kannel WB, Gordon T. Physiological and medical concomitants of obesity: the Framingham study. In:Bray GA, ed. Obesity in America, Washington, DC:DHEW #79-249, 1979;125-153.

  44. Kern PA, Ong JM, Saffari B, Carty J. The effects of weight loss on the activity and expression of adipose tissue lipoprotein lipase in very obese humans. N Engl J Med 1990;322(15):1053-1059.

  45. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74(4):761-811.

  46. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH. Diabetes incidence in PIMA Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981;113:144-156.

  47. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988-1994). Obes Res 1997;5(6):542-548.

  48. Kvist H, Chowhury B, Grangard U, Tylen U, Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988;48:1351-1361.

  49. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984;289:1257-1261.

  50. Larsson B, Bengtsson C, Bjorntorp P, et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Gothenburg, Sweden. Am J Epidemiol 1992;135(3):266-273.

  51. LeMagnen J. Hunger. Cambridge University Press, 1985.

  52. Leibel RL, Chung WK, Chua SC Jr. The molecular genetics of rodent single gene obesities. J Biol Chem 1997;272:31937-31940.

  53. Leibowitz SF. Reciprocal hunger-regulating circuits involving alpha- and beta-adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus. Proc Natl Acad Sci U S A 1970;67(2):1063-1070.

  54. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-576.

  55. Lissner L, Levitsky DA, Strupp BJ, Kalkwark HJ, Roe DA. Dietary fat and the regulation of energy intake in human subjects. Am J Clin Nutr 1991;46(6):886-892.

  56. Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991;324:1839-1844.

  57. Lohman TG. Skinfolds and body density and their relation to body fatness: a review. Hum Biol 1981;53:181-225.

  58. MacMahon SW, Wilcken DE, MacDonald GJ. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986;314:334-339.

  59. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. JAMA 1987;257:353-358.

  60. Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet 1982;1:1165-1168.

  61. Montague CT, Farooqu S, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.

  62. Morley J. Neuropeptide regulation of appetite and weight. Endocr Rev 1987;8:256-287.

  63. Naeye RL. Weight gain and the outcome of pregnancy. Am J Obstet Gynecol 1979;135:3-9.

  64. National Heart Lung & Blood Institute. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. New York: National Heart, Lung & Blood Institute, 1998.

  65. National Task Force on the Prevention and Treatment of Obesity. Weight cycling. JAMA 1994;272:1196-1202.

  66. Nestel PJ, Schreibman PH, Ahrens EH, Jr. Cholesterol metabolism in human obesity. J Clin Invest 1973;52:2389-2397.

  67. Noppa H, Hallstrom T. Weight gain in adulthood in relation to socioeconomic factors, mental illness and personality traits: a prospective study of middle-aged women. J Psychosom Res 1981;25:83-89.

  68. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-1058.

  69. Okada S, York DA, Bray GA, Erlanson-Albertsson C. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav 1991;49(6):1185-1189.

  70. Paredes RG, Agmo A. GABA and behavior: The role of receptor subtypes. Neurosci Biobehav Rev 1992;16:145-170.

  71. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia 41(8):863-881.

  72. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37(12):1596-1607.

  73. Rimm AA, Werner LH, Yserloo BV, Bernstein RA. Relationship of obesity and disease in 73,532 weight-conscious women. Public Health Rep 1975;90:44-54.

  74. Rolls BJ. Sensory-specific satiety. Nutr Rev 1986;44:93-101.

  75. Romieu I, Willett WC, Stampfer MJ, et al. Energy intake and other determinants of relative weight. Am J Clin Nutr 1988;47:406-412.

  76. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA 1991;266:1808-1811.

  77. Scharrer E, Langhans W. Control of food intake by fatty acid oxidation. Am J Physiol 1986;250:R1003-R1006.

  78. Schutz Y, Tremblay A, Weinsier RL, Nelson KM. Role of fat oxidation in the long-term stabilization of body weight in obese women. Am J Clin Nutr 1992;55:670-674.

  79. Segal KR, Van Loan M, Fitzgerald PI, Hodgon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 1988;47:7-14.

  80. Seidell JC, Bakker CJ, van der Krooy K. Imaging techniques for measuring adipose-tissue distribution - a comparison between computed topography and 1.5-T magnetic resonance. Am J Clin Nutr 1990;51(6):953-957.

  81. Sheppard L, Kristal AR, Kushi LH. Weight loss in women participating in a randomized trial of low-fat diets. Am J Clin Nutr 1991;54:821-8.

  82. Sjostrom CD, Lissner L, Sjostrom L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects. Obes Res 1997;5(6):519-530.

  83. Sjostrom L, Rissanen A, Andersen T, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicenter Orlistat Study Group. Lancet 1998;352:167-172.

  84. Society of Actuaries and Association of Life Insurance Medical Directors of America. Society of Actuaries Build study of 1979. Chicago, 1980.

  85. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willet WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992;55:652-658.

  86. Stanley BG, Willett VL 3d, Donias HW, Ha LH, Spears LC. The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 1993;630:41-49.

  87. Stuart RB. Behavioral control of overeating. Behav Res Ther 1967;5:357-365.

  88. Tempel DL, McEwen BS, Leibowitz SF. Effects of adrenal steroid agonists on food intake and macronutrient selection. Physiol Behav 1992;52(6):1161-6.

  89. The Scottish Intercollegiate Guidelines Network. The management of obese patients in Scotland: Integrating a new approach in primary health care with a national prevention and a management strategy. 1996.

  90. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 1995;149(10):1085-1091.

  91. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930-933.

  92. S. Dept of Agriculture. Nutrition and your Health: Dietary Guidelines for Americans, 3rd ed. Home and Garden Bulletin no. 232, 1990.

  93. Vague J. Degree of masculine differentiation of obesities: factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.

  94. Van der Weele D. Insulin and satiety from feeding in pancreatic normal and diabetic rats. Physiol Behav 1993;54(3) in press. [SEE SMITH BOOK]

  95. Waaler HT. Height, weight and mortality: the Norwegian experience. Acta Med Scand 1984;679:1-56.

  96. Wang ZM, Pierson RN, Heymsfield SB. The five-level model: a new approach to organizing body-composition. Am J Clin Nutr 1992;56(1):19-28.

  97. Thomas PR (ed). Weighing the Options: Criteria for evaluating weight-management programs. Washington, DC: National Academy Press, 1995.

  98. Weinsier R, Ullmann DO. Gallstone formation and weight loss: A review. Obes Res 1993;1(1):51-56.

  99. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med 1984;144:1143-1148.

  100. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337(13):869-873.

  101. Willett WC, Browne ML, Bain C, et al. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 1985;122:731-740.

  102. Williamson DF, Kahn HS, Remington PL, et al. The 10-year incidence of overweight and major weight gain in US adults. Arch Int Med 1990;150:665.

  103. Williamson DF, Pamuk ER. The association between weight loss and increased longevity. A review of the evidence. Ann Intern Med 1993;119:731-736.

  104. Wong FL, Trowbridge FL. Nutrition surveys and surveillance: their application to clinical practice. Clin Nutr 1984;36(3):94-99.

  105. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, June 3-5, 1997.

  106. World Health Organization. Report of a WHO study group. Diet, nutrition, and the prevention of chronic diseases. Geneva: World Health Organization Technical Report Series 797, 1990.

  107. Zarich SW, Kowalchuk GJ, McGuire MP, Benotti PN, Mascioli EA, Nesto RW. Left ventricular filling abnormalities in asymptomatic morbid obesity. Am J Cardiol 1991;68:377-381.

  108. Zellisen PMJ. Neuroendocrine regulation in obesity. Thesis. University of Ufrecht. 1991.

  109. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.

  110. Zurlo F, Lillioja S, Esposito-Del Puente A, et al. Low ratio of fat to carbohydrate, oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990;259(5 pt1):E650-657.

Back to Chapter

published 2000